To determine whether cortactin expression could be an independent prognostic factor in HNSCC, we have investigated expression of the protein in a large series of HNSCCs using tissue microarray (TMA) technology and have correlated this expression to the outcome of these patients. Here, CTTN is linked to head and neck squamous cell carcinoma.